Evidence map›Paper›PMID 39312144›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

SHAPE Probing to Screen Computationally Designed RNA.

Pierre Hardouin, Francois-Xavier Lyonnet du Moutier, Bruno Sargueil

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pierre Hardouin *CiTCOM, Cibles Thérapeutiques et Conception de Médicaments, UMR8038 CNRS, Université Paris Cité, Paris, France.
Francois-Xavier Lyonnet du Moutier *CiTCOM, Cibles Thérapeutiques et Conception de Médicaments, UMR8038 CNRS, Université Paris Cité, Paris, France.
Bruno SargueilCiTCOM, Cibles Thérapeutiques et Conception de Médicaments, UMR8038 CNRS, Université Paris Cité, Paris, France. bruno.sargueil@u-paris.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA design is a major challenge for the future development of synthetic biology and RNA-based therapy. The development of efficient and accurate RNA design pipelines is based on trial and error strategies. The fast progression of such algorithms requires assaying the properties of many RNA sequences in a short time frame. High throughput RNA structure chemical probing technologies such as SHAPE-MaP allow for assaying RNA structure and interaction rapidly and at a very large scale. However, the promiscuity of the designed sequences that may differ only by one nucleotide requires special care. In addition, it necessitates the analysis and evaluation of many experimental results that may reveal to be very tedious. Here we propose an experimental and analytical workflow that eases the screening of thousands of designed RNA sequences at once. In particular, we have developed shapemap tools a customized software suite available at https://github.com/sargueil-citcom/shapemap-tools .

Indexed as

AlgorithmsComputational BiologyNucleic Acid ConformationRNASoftwareSynthetic BiologyRNAChemical probingFootprintIPANEMAPRNA structure prediction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.